Literature DB >> 17041472

Ropinirole, open preliminary observations of a dopamine agonist for refractory fibromyalgia.

Andrew J Holman.   

Abstract

Entities:  

Year:  2003        PMID： 17041472     DOI： 10.1097/01.rhu.0000081264.26484.e5

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  6 in total

Review 1.  Management of fibromyalgia syndrome in 2016.

Authors:  Akiko Okifuji; Jeff Gao; Christina Bokat; Bradford D Hare
Journal:  Pain Manag       Date:  2016-06-16

2.  The FIBRO System: A Rapid Strategy for Assessment and Management of Fibromyalgia Syndrome.

Authors:  Chad S Boomershine
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

3.  Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia.

Authors:  Andrew J Holman
Journal:  J Gambl Stud       Date:  2009-02-25

Review 4.  A symptom-based approach to pharmacologic management of fibromyalgia.

Authors:  Chad S Boomershine; Leslie J Crofford
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

5.  Pharmacological treatment of fibromyalgia syndrome: new developments.

Authors:  Roland Staud
Journal:  Drugs       Date:  2010       Impact factor: 9.546

6.  Serotonergic Neurotransmission System Modulator, Vortioxetine, and Dopaminergic D2/D3 Receptor Agonist, Ropinirole, Attenuate Fibromyalgia-Like Symptoms in Mice.

Authors:  Kinga Sałat; Anna Furgała-Wojas
Journal:  Molecules       Date:  2021-04-20       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.